Chao Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chao Peng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Cailiang Shen
Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, 230032, Hefei, China
1 shared publication- Chen Kan
Anhui Medical University, Hefei
1 shared publication Chenghang Zhu
Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, 230022, Hefei, China
1 shared publicationHailin Wang
Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, 230022, Hefei, China
1 shared publication- Haitao Fan
Department of Orthopedics, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, 315010, Ningbo, China.
1 shared publication - Hong Zheng
Department of Pathophysiology, Anhui Medical University, Hefei, China
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (20) , 5890-5917
GNAS/PKA signaling promotes aberrant osteochondral differentiation of Gli1+ tendon sheath progenitors
Tendon injury promotes aberrant osteochondral differentiation of tendon stem cells (TSCs) and results in disability. However, the cellular subsets within the osteochondral lineage involved in this process and associated mechanisms remain unclear. Here, we found that, following Achilles tenotomy, murine Gli1 + tendon sheath cells expanded rapidly, transitioning into tenogenic and osteochondrogenic cells. Lineage tracing, together with single-cell RNA sequencing, revealed that osteochondrogenic Gli1 + tendon sheath cells originate from Scx + tendon stem/progenitor cells, preferentially differentiate into osteochondral lineage tendon progenitors at 7 dpi, subsequently undergoing aberrant chondrogenesis and osteogenesis at 21dpi and 63dpi, respectively. In addition, Acvr1 R206H/+ robustly accelerates osteochondral differentiation in Gli1 + tendon sheath progenitors. Furthermore, GNAS/PKA signaling was significantly activated in osteochondral differentiation of Gli1 + tendon sheath progenitors. Alternatively, treatment with the G sα antagonist, NF449, or genetic inhibition of the PKA subunit, Prkaca , in Gli1 + sheath progenitors significantly alleviated aberrant osteochondral differentiation. NF449 also prevented osteochondral differentiation of human tendon stem cells. These findings identify Gli1 + tendon sheath progenitors with osteochondral differentiation capacity during heterotopic ossification via activation of GNAS/PKA signaling, suggesting PKA as a potentially effective therapeutic target to treat tendon ossification.
- 1 September 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (20) , 5890-5917
Open AccessGNAS/PKA signaling promotes aberrant osteochondral differentiation of Gli1+ tendon sheath progenitors
Tendon injury promotes aberrant osteochondral differentiation of tendon stem cells (TSCs) and results in disability. However, the cellular subsets within the osteochondral lineage involved in this process and associated mechanisms remain unclear. Here, we found that, following Achilles tenotomy, murine Gli1 + tendon sheath cells expanded rapidly, transitioning into tenogenic and osteochondrogenic cells. Lineage tracing, together with single-cell RNA sequencing, revealed that osteochondrogenic Gli1 + tendon sheath cells originate from Scx + tendon stem/progenitor cells, preferentially differentiate into osteochondral lineage tendon progenitors at 7 dpi, subsequently undergoing aberrant chondrogenesis and osteogenesis at 21dpi and 63dpi, respectively. In addition, Acvr1 R206H/+ robustly accelerates osteochondral differentiation in Gli1 + tendon sheath progenitors. Furthermore, GNAS/PKA signaling was significantly activated in osteochondral differentiation of Gli1 + tendon sheath progenitors. Alternatively, treatment with the G sα antagonist, NF449, or genetic inhibition of the PKA subunit, Prkaca , in Gli1 + sheath progenitors significantly alleviated aberrant osteochondral differentiation. NF449 also prevented osteochondral differentiation of human tendon stem cells. These findings identify Gli1 + tendon sheath progenitors with osteochondral differentiation capacity during heterotopic ossification via activation of GNAS/PKA signaling, suggesting PKA as a potentially effective therapeutic target to treat tendon ossification.